Region:  
 
      Advanced
Search
 
Bookmark and Share 
  
Find An Educational Offering
Select Search Criteria
Keyword:
Events starting on or after:  mm/dd/yyyy
Events Added:
Region:
Interest Areas (IA): Hold the CTRL key to select or de-select multiple items from adjacent list box

     
Event Type: Hold the CTRL key to select or de-select multiple items from adjacent list box

 
 
  Click here to Expand the Tab 
10651 CTD Dossier Requirements: Focus on EU Module 1 and Quality Module 3
 Overview 
 Agenda / Committee 
 Continuing Education 
 Tutorial / Sub-Events 
 Exhibits 
 Travel/Hotel Information 
 Registration Fees 
 Related Offerings 
 Highlights 
Title:
CTD Dossier Requirements: Focus on EU Module 1 and Quality Module 3


Date(s) And Time(s):
Mar 24 2010 8:00AM - Mar 25 2010 5:30PM

Location:
Taj Banjara
Road No. 1
Banjara Hills
Hyderabad 500034
Andhra Pradesh
India

Interest Area(s):
Regulatory Affairs,Clinical Research,Public Policy/Law/Corp. Compliance,Research & Development,Project Management

Overview:

Techniques to Ensure High Quality Registration Dossiers Facilitate the Registration Procedure for Generics.

This Module provides a comprehensive description on the Common Technical Dossier structure —
completely updated to reflect the latest changes in pharmaceutical regulatory affairs. The course is
focusing on the specific regional EU requirements for Module 1 including discussion of the relevant
legislation. The requirements for the Quality documentation (Module 2.3 & 3) will be presented in detail,
taking into account the recent ICH-Q guidelines.

The course is for new developments, but is also very much attractive for Generics. In addition, this
training course addresses Quality by Design aspects and issues.

Featured Topics
CTD, eCTD
EU Module 1
• Cover Letter
• Application Forms
• Product Information
• Environmental Risk Assessment
• Information relating to Orphan Market Exclusivity
• Risk-management System
• Paediatric Information
Module 3
• Pharmaceutical Development and Quality Risk Management
• Quality of Active Substance including Purity Issues
• Impurity Testing
• Stability Testing
• Setting of Specifications
• Pharmaceutical Quality System



Learning Objectives:
At the conclusion of this course, participants should be able to:
• Identify the recent requirements for developing drug substance and drug products and setting up a
  registration dossier — especially for generics
• Define the requirements for developing a product and discuss how to prepare the regional EU
  Module 1 and the Quality documentation
• Discuss the legal background of the dossier requirements and identify the relevant guidelines
• Demonstrate optimal presentation of information and justifications


Target Audience:
 Governmental institutions
• Pharmaceutical industry professionals
• Development managers and experts
• QA and new manufacturing managers


Event Code:
10651

Contact Information:

Fahd Khan, Manager Marketing & Program Development, DIA (India) Private Limited;
Cell: +91-9223267327, Fax: +91-22-28594762, Email: Fahd.Khan@diahome.org

Vinisha Bhavsar, Program & Operations Assistant, DIA (India) Private Limited;
Cell: +91-9004682564; Fax: +91-22-2859-4762; Email:
dia.diaindia@gmail.com